- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Ashfield Engage Partners with ysura to “Transform HCP and Pharma Interactions” in Europe
Ashfield Engage (Ashby-de-la-Zouch, UK), a strategic engagement and commercialization partner for the healthcare industry, has partnered with ysura (Munich, Germany), a SaaS company specializing in healthcare, to enhance its HCP engagement services in Europe through a “seamless omnichannel solution.”
Ashfield Engage helps clients engage with healthcare professionals (HCPs) through a blend of sales, account management and medical science liaison teams across digital, virtual and in-person channels. ysura’s proprietary, cloud-based Customer Interaction Platform helps them more precisely reach audience segments and provide richer and more personalized HCP conversations.
The Ashfield Engage Customer Engagement Platform powered by ysura will be rolled out across Europe in early 2022.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
